Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
27 Diciembre 2023 - 3:15PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a)
of
the Securities Exchange Act of 1934
Filed by the Registrant |
☒ |
Filed by party other than the registrant |
☐ |
Check
the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive additional materials |
☐ | Soliciting material under Rule 14a-12 |
180
LIFE SCIENCES CORP.
(Name
of Registrant as Specified in Charter)
Payment
of Filing Fee (Check all boxes that apply):
☐ | Fee
paid previously with preliminary materials |
☐ | Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and
0-11 |
|
CONTROL
ID: |
|
180
LIFE SCIENCES CORP. |
REQUEST
ID: |
|
IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
for a Special Meeting of Stockholders |
|
DATE: |
Friday,
February 16, 2024 |
|
TIME: |
9:00
A.M. pacific time |
|
LOCATION: |
https://agm.issuerdirect.com/atnf
|
|
|
|
HOW
TO REQUEST PAPER COPIES OF OUR MATERIALS |
|
|
|
|
PHONE:
Call
toll free
1-866-752-8683
|
FAX:
Send
this card to
202-521-3464
|
INTERNET:
https://www.iproxydirect.com/atnf
and follow the on-screen instructions. |
EMAIL:
proxy@iproxydirect.com
Include your Control ID in your email.
|
|
This
communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage
you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is
available at: https://www.iproxydirect.com/ATNF |
|
If
you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy. To
facilitate timely delivery please make the request, as instructed above, before February 2, 2024. |
|
you
may enter your voting instructions at https://www.iproxydirect.com/ATNF
until
11:59 pm Pacific Time February 15, 2024. |
|
The
purposes of this meeting are as follows: |
1.
To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse
stock split of the Company’s issued and outstanding shares of the Company’s common stock, par value $0.0001 per share,
by a ratio of between one-for-four and one-for-forty, inclusive, with the exact ratio to be set at a whole number to be determined
by the Company’s board of directors or a duly authorized committee thereof in its discretion, at any time after approval of
the amendment and prior to February 16, 2025 (the “Reverse Split Proposal”);
2.
To approve the adoption of the Second Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan;
3. to
approve the issuance of more than 19.99% of the Company’s outstanding common stock upon the exercise of certain warrants (the
“Nasdaq Proposal”); and
4.
to approve the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes
at the time of the Special Meeting to approve the Reverse Split Proposal or Nasdaq Proposal.
|
Pursuant
to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Special Meeting are available
on the Internet. Follow the instructions above to view the materials and vote or request printed copies.
The
board of directors has fixed the close of business on December 18, 2023, as the record date for the determination of stockholders entitled
to receive notice of the Special Meeting and to vote the shares of our common stock and preferred stock, they held on that date at the
meeting or any postponement or adjournment of the meeting.
|
The
Board of Directors recommends that you vote ‘for’ all proposals above. |
|
Please
note - This is not a Proxy Card - you cannot vote by returning this card |
|
|
|
|
|
|
180
Life Sciences Corp.
SHAREHOLDER
SERVICES
1
Glenwood Avenue Suite 1001
Raleigh
NC 27603 |
FIRST-CLASS
MAIL
US
POSTAGE
PAID
RALEIGH
NC
PERMIT
# 870 |
Time
Sensitive shareholder information enclosed
IMPORTANT
SHAREHOLDER INFORMATION
your
vote is important
180 Life Sciences (NASDAQ:ATNF)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
180 Life Sciences (NASDAQ:ATNF)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025